Profitability
Weight: 25%
F
14
- 5yr Avg ROIC 2.0%
- Operating Margin Trend -4.35 pp/yr
PCRX
Pacira BioSciences, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
D-
32
- 5yr Avg ROE 0.2%
- 5yr Share-Count CAGR -0.3%
Growth Quality
Weight: 25%
C
53
- 5yr Revenue CAGR 7.6%
- 5yr EPS CAGR -35.4%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
B+
78
- 5yr FCF Margin 19.4%
- 5yr FCF/NI Conversion 7.97x
Balance Sheet
Weight: 10%
C
52
- Net Debt / EBITDA 1.76x
- Interest Coverage (EBIT/Int) 2.16x
- Altman Z-Score 1.85
Stability
Weight: 5%
C
52
- EPS Volatility (σ/μ) 1.29
- Piotroski F-Score 8
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 added; 1 trimmed.
- Holders
- 2
- Avg Δ position
- +16.8%
- New buys
- 0
- Full exits
- 0
- Greenblatt increased +36%
- Cooperman decreased -3%